Evidence map›Paper›PMID 33720269›Full record

ArticleLab on a chip2021

Fundamentals of integrated ferrohydrodynamic cell separation in circulating tumor cell isolation.

Yang Liu, Wujun Zhao, Rui Cheng, Bryana N Harris, Jonathan R Murrow, Jamie Hodgson, Mary Egan, Anastacia Bankey, Petros G Nikolinakos, Travis Laver and 2 more

Open access · greenAbstract read
In one paragraph

Article in Lab on a chip, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. [Recent advances in responsive isolation, release and clinical application of circulating tumor cells].Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2024
    Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Yang LiuDepartment of Chemistry, The University of Georgia, Athens, GA 30602, USA.ORCID 0000-0002-8747-4975
Wujun ZhaoDepartment of Chemistry, The University of Georgia, Athens, GA 30602, USA.
Rui ChengSchool of Electrical and Computer Engineering, College of Engineering, The University of Georgia, Athens, GA 30602, USA. mao@uga.edu.
Bryana N HarrisDepartment of Chemical Engineering, Auburn University, Auburn, AL 36830, USA.
Jonathan R MurrowDepartment of Medicine, Augusta University - The University of Georgia Medical Partnership, Athens, GA 30602, USA.
Jamie HodgsonUniversity Cancer & Blood Center, LLC, Athens, GA 30607, USA.
Mary EganUniversity Cancer & Blood Center, LLC, Athens, GA 30607, USA.
Anastacia BankeyUniversity Cancer & Blood Center, LLC, Athens, GA 30607, USA.
Petros G NikolinakosUniversity Cancer & Blood Center, LLC, Athens, GA 30607, USA.
Travis LaverSmall Animal Medicine and Surgery, Veterinary Teaching Hospital, The University of Georgia, Athens, GA 30602, USA.
Kristina MeichnerDepartment of Pathology, College of Veterinary Medicine, The University of Georgia, Athens, GA 30602, USA.
Leidong MaoSchool of Electrical and Computer Engineering, College of Engineering, The University of Georgia, Athens, GA 30602, USA. mao@uga.edu.ORCID 0000-0001-9473-5590
University of Georgia · USUniversity Cancer and Blood Center · USAuburn University · US

Funding

Implementing a Maternal health and PRegnancy Outcomes Vision for Everyone (IMPROVE)UL1TR002378 · NCATS · EMORY UNIVERSITY · PI Andres J Garcia, Elizabeth O. Ofili · 2017 to 2026
$92.1M
NCATS NIH HHS UL1 TR002378
6 · The paper itself

Abstract

Methods to separate circulating tumor cells (CTCs) from blood samples were intensively researched in order to understand the metastatic process and develop corresponding clinical assays. However current methods faced challenges that stemmed from CTCs' heterogeneity in their biological markers and physical morphologies. To this end, we developed integrated ferrohydrodynamic cell separation (iFCS), a scheme that separated CTCs independent of their surface antigen expression and physical characteristics. iFCS integrated both diamagnetophoresis of CTCs and magnetophoresis of blood cells together via a magnetic liquid medium, ferrofluid, whose magnetization could be tuned by adjusting its magnetic volume concentration. In this paper, we presented the fundamental theory of iFCS and its specific application in CTC separation. Governing equations of iFCS were developed to guide its optimization process. Three critical parameters that affected iFCS's cell separation performance were determined and validated theoretically and experimentally. These parameters included the sample flow rate, the volumetric concentration of magnetic materials in the ferrofluid, and the gradient of the magnetic flux density. We determined these optimized parameters in an iFCS device that led to a high recovery CTC separation in both spiked and clinical samples.

Indexed as

Neoplastic Cells, CirculatingCell CountCell Line, TumorCell SeparationHumans

Identifiers

PMID33720269
PMCPMC8102387
OpenAlexW3134794768

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.